These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36745456)

  • 1. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N;
    JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
    Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
    Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
    Lv J; Wong MG; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Zhao M; Barbour S; Jardine MJ; Reich HN; Cattran D; Glassock R; Levin A; Wheeler DC; Woodward M; Billot L; Stepien S; Rogers K; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Zhang H; Perkovic V;
    JAMA; 2022 May; 327(19):1888-1898. PubMed ID: 35579642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.
    Frisch G; Lin J; Rosenstock J; Markowitz G; D'Agati V; Radhakrishnan J; Preddie D; Crew J; Valeri A; Appel G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2139-45. PubMed ID: 16030050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term study of mycophenolate mofetil treatment in IgA nephropathy.
    Tang SC; Tang AW; Wong SS; Leung JC; Ho YW; Lai KN
    Kidney Int; 2010 Mar; 77(6):543-9. PubMed ID: 20032964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
    Lv J; Zhang H; Wong MG; Jardine MJ; Hladunewich M; Jha V; Monaghan H; Zhao M; Barbour S; Reich H; Cattran D; Glassock R; Levin A; Wheeler D; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Wang HY; Perkovic V;
    JAMA; 2017 Aug; 318(5):432-442. PubMed ID: 28763548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
    Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study.
    Zhao J; Ma F; Bai M; Sun S
    Clin Ther; 2021 May; 43(5):859-870. PubMed ID: 33863547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ; Yang YZ; Shi SF; Bao YF; Yang C; Zhu SN; Sui GL; Chen YQ; Lv JC; Zhang H
    Am J Kidney Dis; 2019 Jul; 74(1):15-22. PubMed ID: 30922594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil.
    Chen Z; Chen W; Zheng L; Xie Y; Yao K; Zhou T
    Curr Pharm Des; 2024; 30(30):2400-2409. PubMed ID: 38988169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review.
    Tan CH; Loh PT; Yang WS; Chan CM
    Singapore Med J; 2008 Oct; 49(10):780-5. PubMed ID: 18946610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
    Frutos MA; López V; Alférez MJ; Aranda P
    Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.
    Maes BD; Oyen R; Claes K; Evenepoel P; Kuypers D; Vanwalleghem J; Van Damme B; Vanrenterghem YF
    Kidney Int; 2004 May; 65(5):1842-9. PubMed ID: 15086925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.
    Dussol B; Morange S; Burtey S; Indreies M; Cassuto E; Mourad G; Villar E; Pouteil-Noble C; Karaaslan H; Sichez H; Lasseur C; Delmas Y; Nogier MB; Fathallah M; Loundou A; Mayor V; Berland Y
    Am J Kidney Dis; 2008 Oct; 52(4):699-705. PubMed ID: 18585835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
    Liu T; Wang Y; Mao H; Yang L; Zhan Y
    Medicine (Baltimore); 2021 Feb; 100(8):e24541. PubMed ID: 33663060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.